Two seminal studies report a bioengineering approach to modeling CAR-T cell therapy of solid human tumors.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 /Â 30Â days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout

References
Liu, H. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-025-02845-z (2025).
Maulana, T. I. et al. Cell Stem Cell 31, 989â1002.e9 (2024).
Huh, D. et al. Science 328, 1662â1668 (2010).
Khetani, S. R. & Bhatia, S. N. Nat. Biotechnol. 26, 120â126 (2008).
Ronaldson-Bouchard, K. et al. Nature 556, 239â243 (2018).
Ronaldson-Bouchard, K. et al. Nat. Biomed. Eng. 6, 351â371 (2022).
Sadelain, M., Rivière, I. & Riddell, S. Nature 545, 423â431 (2017).
June, C. H. & Sadelain, M. N. Engl. J. Med. 379, 64â73 (2018).
Hou, A. J., Chen, L. C. & Chen, Y. Y. Nat. Rev. Drug Discov. 20, 531â550 (2021).
Chen, N., Li, X., Chintala, N. K., Tano, Z. E. & Adusumilli, P. S. Curr. Opin. Immunol. 51, 103â110 (2018).
Albelda, S. M. Nat. Rev. Clin. Oncol. 21, 47â66 (2024).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Vunjak-Novakovic, G. Tumor-on-chip models of CAR-T cell therapy. Nat Biotechnol (2025). https://doi.org/10.1038/s41587-025-02819-1
Published:
DOI: https://doi.org/10.1038/s41587-025-02819-1